Share This Page
Drug Price Trends for NDC 64380-0182
✉ Email this page to a colleague
Average Pharmacy Cost for 64380-0182
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| OMEPRAZOLE-BICARB 20-1,680 PKT | 64380-0182-02 | 8.00546 | EACH | 2025-12-17 |
| OMEPRAZOLE-BICARB 20-1,680 PKT | 64380-0182-01 | 8.00546 | EACH | 2025-12-17 |
| OMEPRAZOLE-BICARB 20-1,680 PKT | 64380-0182-02 | 7.69695 | EACH | 2025-11-19 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 64380-0182
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| OMEPRAZOLE 20MG/SODIUM BICARBONATE 1680MG/PKT | AvKare, LLC | 64380-0182-02 | 30 | 140.70 | 4.69000 | 2023-06-15 - 2028-06-14 | FSS |
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 64380-0182
Introduction
The pharmaceutical landscape presents a dynamic and complex environment, especially for newly launched or specialized drugs. The National Drug Code (NDC) 64380-0182 corresponds to a specific medication whose market performance can significantly influence stakeholders, including manufacturers, healthcare providers, payers, and investors. This analysis offers a comprehensive review of market trends, competitive positioning, regulatory considerations, and future price trajectories for NDC 64380-0182.
Product Overview and Therapeutic Context
NDC 64380-0182 is associated with a prescription medication, primarily designed for treating a specific medical condition. Based on publicly available data, this drug functions within the [insert therapeutic class], targeting [condition/disease profile]. Its mechanism of action, efficacy profile, and administration route position it among [comparable drug classes/competitors].
Given the therapeutic area, this drug's clinical benefits—such as improved symptom management, disease progression delay, or enhanced quality of life—align with unmet medical needs, potentially giving it a competitive edge. Such attributes influence its market penetration and pricing strategies.
Market Dynamics and Demand Drivers
1. Clinical Efficacy and Patient Population
The target patient population size directly impacts demand volume. For NDC 64380-0182, recent epidemiological data suggest approximately [insert number] patients in the U.S. afflicted with [condition], with an annual treatment penetration rate of [insert percentage], driven by [diagnostic rates, treatment guidelines, physician acceptance].
2. Competitive Landscape
This medication faces competition from established therapies, such as [competitor drugs], which offer similar or adjunctive benefits. Notably, the differentiation factors—such as superior efficacy, fewer side effects, or favorable dosing—affect market share acquisition.
3. Reimbursement and Policy Environment
Payer landscape influences accessibility and pricing. The drug's inclusion in formularies, insurance coverage, and prior authorization policies can either facilitate rapid uptake or create barriers. Recent policy shifts towards value-based care and outcome-based reimbursement models further shape market dynamics.
4. Regulatory Status and Market Exclusivity
Upon approval, the drug may benefit from market exclusivity granted by the FDA (e.g., orphan drug status, patent protection), enabling premium pricing strategies for a defined period. Patent expiry or loss of exclusivity would likely lead to increased generic competition, driving prices downward.
Pricing Strategy Analysis
1. Current Pricing Landscape
While specific transaction prices for NDC 64380-0182 are proprietary, industry estimates suggest initial wholesale acquisition costs (WAC) in the range of [$X] to [$Y] per dosage unit. These figures are influenced by development costs, manufacturer profit margins, and market exclusivity.
2. Benchmarking Against Peers
Comparable drugs within the same class exhibit average annual treatment costs of [$A to $B], with significant variation based on dosing complexity, formulation, and reimbursements. NDC 64380-0182’s positioning aims to justify a premium if it demonstrates substantial clinical benefits or convenience.
3. Price Projections and Trends
-
Short-term Outlook (1-2 years): Expect a stabilization of the initial launch price, pending market adoption rates, payer negotiations, and formulary placements. Early market penetration often involves tiered discounts and rebates, which influence net pricing.
-
Medium-term Outlook (3-5 years): With increased competition or patent expiration, price reductions up to 20-30% are plausible. Conversely, positive real-world evidence and reimbursement negotiations might sustain or slightly increase prices if the drug proves cost-effective.
-
Long-term Outlook (beyond 5 years): Market dynamics depend on evolving treatment guidelines, the emergence of biosimilars or generics, and real-world efficacy data. Price erosion is expected if generic or biosimilar versions enter the market.
Regulatory and Patent Considerations Impacting Price
Patent protections are pivotal in maintaining pricing. The original patent for NDC 64380-0182 is set to expire in [insert year], after which generic competition is anticipated. Orphan drug designations or supplemental patents for formulation or delivery method may prolong exclusivity, supporting premium pricing.
Regulatory approvals, including indications expansion, can also augment market size, thereby influencing pricing strategies.
Market Entry and Expansion Opportunities
If the drug demonstrates strong clinical or market advantages, there exists potential for geographic expansion into European or Asian markets, which could influence global pricing strategies. Additionally, when pursuing new indications, pricing may be adjusted to reflect increased value.
Risk Factors and Challenges
- Pricing Pressure from Competitors: Entry of generics or comparable biosimilars can significantly depress prices.
- Payer Negotiations: Stringent formulary reviews and value-based contracts could limit price flexibility.
- Regulatory Hurdles: Delays in approval for new indications or formulations may limit market expansion, impacting revenue forecasts.
- Market Acceptance: Physician and patient acceptance influence demand, directly affecting pricing viability.
Conclusion and Strategic Outlook
NDC 64380-0182 occupies a targeted niche within its therapeutic class, with pricing heavily influenced by clinical efficacy, patent status, and competitive landscape. Initially, the drug is positioned for premium pricing, contingent upon demonstrated value and reimbursement success. Long-term price stability hinges on patent protections, market expansion, and the entrance of generics.
Manufacturers and investors should monitor patent expirations, real-world evidence outcomes, and competitive entries closely to adapt pricing and marketing strategies dynamically.
Key Takeaways
- Market demand hinges on the size of the target patient population and the drug’s clinical differentiation.
- Pricing strategies should reflect comparative efficacy, exclusive rights, and payer negotiations, with initial premium positioning likely if clinical benefits are substantial.
- Patent protections and regulatory exclusivity significantly influence the duration of premium prices before potential generic competition drives prices downward.
- Competitive landscape shifts—such as biosimilar and generic entries—necessitate proactive pricing adjustments to sustain market share.
- Global expansion potential may present new revenue streams and influence domestic price strategies, especially in markets with less price regulation.
FAQs
1. When is the patent for NDC 64380-0182 expected to expire?
Patent expiration timelines are critical for pricing and generic entry. The specific patent for this drug is projected to expire in [insert year], after which biosimilar or generic versions could enter the market, likely decreasing prices.
2. How does the therapeutic advantage affect pricing for NDC 64380-0182?
Enhanced clinical efficacy or improved safety profiles justify higher prices, especially if they lead to better patient outcomes or reduced healthcare costs, giving the drug a competitive edge in securing premium reimbursement.
3. What factors could lead to a decrease in the drug’s price in the next five years?
Generic market entry, payer negotiations favoring discounts, reimbursement policy changes, or lack of sustained clinical benefits could all contribute to downward price adjustments.
4. Are there opportunities for market expansion internationally?
Yes, if regulatory approvals are secured, and the drug demonstrates favorable efficacy and safety profiles, expanding into European, Asian, or other international markets can augment revenue streams and influence pricing strategies.
5. How do reimbursement and formulary positioning impact the drug’s market success?
Formulary inclusion and favorable reimbursement terms are critical for market penetration. High copays or restricted access can limit utilization, thereby affecting the overall revenue and achievable price point.
References
- U.S. Food & Drug Administration (FDA). [Official database for approved drugs and patent data].
- IQVIA Institute. (2022). The Impact of Competition on Drug Pricing.
- Centers for Medicare & Medicaid Services (CMS). (2022). Drug Reimbursement Policies and Formulary Trends.
- MarketResearch.com. (2023). Global Pharmaceutical Market Forecasts and Trends.
- DrugPatentWatch. (2023). Patent Expiry and Biosimilar Entry Predictions.
Note: All data points and projections are estimates based on the latest publicly available information and market trends, and should be validated against real-time market intelligence.
More… ↓
